SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001520138-23-000181
Filing Date
2023-04-07
Accepted
2023-04-06 17:44:10
Documents
14
Period of Report
2023-04-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bivi-20230406_8k.htm   iXBRL 8-K 41085
2 EX-5.1 bivi-20230406_8kex5z1.htm EX-5.1 13325
3 GRAPHIC image_001.jpg GRAPHIC 4321
  Complete submission text file 0001520138-23-000181.txt   239426

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bivi-20230406.xsd EX-101.SCH 3239
5 XBRL LABEL FILE bivi-20230406_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bivi-20230406_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20230406_8k_htm.xml XML 3605
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 23807317
SIC: 2834 Pharmaceutical Preparations